Scientific Program

  • Thursday, March 14
  • Friday, March 15
  • Saturday, March 16

Thursday, March 14

[JS01] KAI-KSH Joint Symposium: Immunotherapeutics in Blood Disease

Date & Time March 14 (Thursday) 09:00-10:30 Room Vista I
Chairs Tae Woo Kim (Korea University College of Medicine, Korea)
Je-Jung Lee (Chonnam National University Medical School, Korea)
Presentations

IL-7-hyFc, a long-acting recombinant IL-7 protein, generates anti-tumor activity by modulating both adaptive and innate immune cells in the tumor microenvironment

Seung-Woo Lee (POSTECH, Korea)

Towards next-generation CAR-T cell therapy for cancer

Chan Hyuk Kim (KAIST, Korea)

Immunotherapeutics in blood disease: Cytotoxic T lymphocyte therapy

Hyewon Lee (National Cancer Center, Korea)

Immune checkpoint inhibitor in lymphoma

Yoon Seok Choi (Chungnam National University College of Medicine, Korea)

[SS01] Scientific Session 1: Bone Marrow Failure

Date & Time March 14 (Thursday) 09:00-10:30 Room Vista II
Chairs Hoon Kook (Chonnam National University Medical School, Korea)
Jean Soulier (University Paris Diderot, France)
Presentations

Paroxysmal nocturnal hemoglobinuria in bone marrow failure

Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)

Germline mutations in inherited bone marrow failure

Jean Soulier (University Paris Diderot, France)

Telomere length and somatic mutations in aplastic anemia

Dong Soon Lee (Seoul National University School of Medicine, Korea)

[PL01] Plenary Lecture I: Gene Therapy in Hematology

Date & Time March 14 (Thursday) 10:45-11:45 Room Vista I+II+III
Chair Chan-Jeoung Park (University of Ulsan College of Medicine, Korea)
Presentations

Application of CRISPR/Cas-9 in blood disease

Matthew H. Porteus (Stanford Medical School, Stanford University, USA)

Gene therapy for hemophilia-will there be a new era in hemophilia treatment?

Katherine Ann High (Spark Therapeutics Inc., USA)

[PS] Presidential Symposium

Date & Time March 14 (Thursday) 11:45-12:45 Room Vista I+II+III
Chair Bin Cho (College of Medicine, The Catholic University of Korea, Korea)
Presentations

Stem cells in human AML

Ravi Majeti (Stanford University, USA)

Precision medicine in pediatric acute lymphoblastic leukemia

Ching-Hon Pui (St. Jude Children's Research Hospital, USA)

[LS01] Novartis

Date & Time March 14 (Thursday) 12:45-13:35 Room Vista I
Chair Dong-Wook Kim (College of Medicine, The Catholic University of Korea, Korea)
Presentations

Treatment free remission in CML: Promise and challenges

Adam Mead (University of Oxford, UK)

[LS02] Amgen

Date & Time March 14 (Thursday) 12:45-13:35 Room Vista II+III
Chair Chang-Ki Min (College of Medicine, The Catholic University of Korea, Korea)
Presentations

Optimal treatment sequencing for patients with relapsed/refractory multiple myeloma

Ajai Chari (Mount Sinai Hospital, USA)

[LS03] Roche

Date & Time March 14 (Thursday) 12:45-13:35 Room Grand Hall
Chair Hyeon-Seok Eom (Center for Hematologic Malignancy, National Cancer Center, Korea)
Presentations

Current issues in the treatment of B-cell lymphoma

Seok Jin Kim (Sungkyunkwan University school of Medicine, Korea)

[AS01] Asian Hematology Symposium I: Lymphoid

Date & Time March 14 (Thursday) 13:40-14:40 Room Vista I
Chairs Seok Lee (College of Medicine, The Catholic University of Korea, Korea)
Tran-Der Tan (Koo Foundation Sun Yat-Sen Cancer Center, Taiwan)
Presentations

Treatment of Philadelphia chromosome positive acute lymphoblastic leukemia- Korean perspectives

Young Rok Do (Keimyung University School of Medicine, Korea)

Hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia in Taiwan – On Behalf of TSBMT

Tran-Der Tan (Koo Foundation Sun Yat-Sen Cancer Center, Taiwan)

Adult ALL in Malaysia

Sen Mui Tan (Hospital Ampang, Malaysia)

[AS02] Asian Hematology Symposium II: Myeloid

Date & Time March 14 (Thursday) 13:40-14:40 Room Vista II
Chairs Won Sik Lee (Inje University School of Medicine, Korea)
Bach Quoc Khanh (Director - National Institute of Hematology and Blood Transfusion Vice President & General Secretary - Vietnam Society of Hematology and Blood Transfusion, Vietnam)
Presentations

CML in Philippines

Priscilla B. Caguioa (University of Santo Tomas Hospital, St. Luke’s Medical Center, Philippines)

Outcome of allogeneic hematopoietic stem cell transplantation for SAA and PNH at Vietnam national institute of haematology and blood transfusion

Binh Thi Thanh VO (National Institute of Hematology and Blood Transfusion, Vietnam)

Hemoglobinopathy in Thailand

Duantida Songdej (Ramathibodi Hospital, Mahidol University, Thailand)

[JS02] KOGO-KSH Joint Symposium: Genomics for Precision Hematology

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista I
Chairs Sanghyuk Lee (Ewha Womans University School of Medicine, Korea)
Sun-Hee Kim (Sungkyunkwan University School of Medicine, Korea)
Presentations

Understanding angioimmunoblastic T-cell lymphoma: From genomics to animal pathology

Jaesang Kim (Department of Life Science, Ewha Womans University, Korea)

Genomic pathogenesis of Epstein–Barr Virus (EBV)-induced diffuse large B cell lymphoma

Sung-Yup Cho (Seoul National University College of Medicine, Korea)

Current status of precision hematology

Young-Uk Cho (University of Ulsan College of Medicine, Korea)

Clinical application of personalized medicine for AML

Joon-ho Moon (Kyungpook National University Hospital, Korea)

[SS02] Scientific Session 2: Multiple Myeloma-How is Multiple Myeloma Developed and Progressed? From 3 Different Viewpoint

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista II
Chairs Chang-Ki Min (College of Medicine, The Catholic University of Korea, Korea)
Yusuke Furukawa (Jichi Medical University, Japan)
Presentations

Immunological weapons against multiple myeloma

Je-Jung Lee (Chonnam National University Medical School, Korea)

Roles of bone marrow microenvironment in clonal evolution and drug resistance of multiple myeloma

Yusuke Furukawa (Jichi Medical University, Japan)

Antigen-mediated regulation in myeloma

Madhav V. Dhodapkar (Emory University, USA)

[SS03] Scientific Session 3: Transplantation/Cell Therapy

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista III
Chairs Hyeon-Seok Eom (Center for Hematologic Malignancy, National Cancer Center, Korea)
Maria Chiara Bonini (Università Vita-Salute San Raffaele, Italy)
Presentations

TK cell therapy

Maria Chiara Bonini (Università Vita-Salute San Raffaele, School of Medicine, Italy)

Updates on CAR T cell therapy for multiple myeloma

Jesús G. Berdeja (Sarah Cannon Research Institute, USA)

Accelerating personalization of immune therapies for blood cancers

Larry W. Kwak (City of Hope Comprehensive Cancer Center, USA)

[ES01] Educational Session 1: Iron Metabolism

Date & Time March 14 (Thursday) 14:55-16:25 Room Grand Hall
Chairs Joon Seong Park (Ajou University School of Medicine, Korea)
Heather Alice Leitch (University of British Columbia, Canada)
Presentations

Iron metabolism in hemoglobinopathies

Vip Viprakasit (Medicine Siriraj Hospital, Mahidol University, Thailand)

Deferasirox for iron overload patients: Preserving organ functions

Norbert Gattermann (Heinrich Heine University, Düsseldorf, Germany)

Management of iron overload in MDS

Heather Alice Leitch (University of British Columbia, Canada)

[SS04] Scientific Session 4: Myeloproliferative Neoplasm

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista I
Chairs Chul Won Choi (Korea Univertsity Guro Hospital, Korea)
Robert Kralovics (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria)
Presentations

Genetic causes of myeloproliferative diseases: Stratification of patients and new therapeutic targets

Robert Kralovics (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria)

Molecular mechanism of MPN development by mutant calreticulin

Norio Komatsu (Juntendo University School of Medicine, Japan)

Interferon in myeloproliferative neoplasms

Jean-Jacques Kiladjian (Saint-Louis Hospital and Paris 7 University, France)

[SS05] Scientific Session 5: Bleeding Disorder/Thrombosis

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista II
Chairs Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
Glenn F. Pierce (World Federation of Hemophilia, USA)
Presentations

Progress in gene therapy for hemophilia A and B

Glenn F. Pierce (World Federation of Hemophilia, USA)

Individualized treatment for hemophilia: Population pharmacokinetics approach

Cindy H. T. Yeung (McMaster University, Canada)

Mechanisms of cancer-associated thrombosis

Nigel Mackman (University of North Carolina, USA)

[SS06] Scientific Session 6: Pediatric Disease: Inherited hematologic malignancies

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista III
Chairs Nack Gyun Chung (College of Medicine, The Catholic University of Korea, Korea)
Lucy Ann Godley (The University of Chicago, USA)
Presentations

Inherited hematologic malignancies

Lucy Ann Godley (The University of Chicago, USA)

GATA2 deficiency: How to make the diagnosis? how to treat it?

Jean Donadieu (Hopital Trousseau, France)

Roles of Monosomy 7 and SAMD9/SAMD9L mutations in myeloid leukemogenesis

Hirotaka Matsui (Kumamoto University, Japan)

[ES02] Educational Session 2: Indolent Lymphoma: From Genetics to the Clinic

Date & Time March 14 (Thursday) 16:40-18:10 Room Grand Hall
Chairs Inho Kim (Seoul National University College of Medicine, Korea)
Mats Jerkeman (Lund University, Sweden)
Presentations

Mantle cell lymphoma -from the clinic to genetics

Mats Jerkeman (Lund University, Sweden)

From genetics to the clinic: Follicular lymphoma

Gilles Salles (Université Claude Bernard Lyon—1 (UCBL), France)

From genetics to the clinic of chronic lymphocytic leukemia

Wei Xu (First Affiliated Hospital of Nanjing Medical University, China)


[Close]